Authors:
SCHOBER HC
HAN ZH
FOLDES AJ
SHIH MS
RAO DS
BALENA R
PARFITT AM
Citation: Hc. Schober et al., MINERALIZED BONE LOSS AT DIFFERENT SITES IN DIALYSIS PATIENTS - IMPLICATIONS FOR PREVENTION, Journal of the American Society of Nephrology, 9(7), 1998, pp. 1225-1233
Citation: I. Fogelman et al., A 1-YEAR OPEN-LABEL FOLLOW-UP-STUDY IN 121 POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH CYCLICAL ETIDRONATE, Journal of bone and mineral research, 12, 1997, pp. 276-276
Authors:
DELMAS PD
BALENA R
CONFRAVREUX E
HARDOUIN C
HARDY P
BREMOND A
Citation: Pd. Delmas et al., BISPHOSPHONATE RISEDRONATE PREVENTS BONE LOSS IN WOMEN WITH ARTIFICIAL MENOPAUSE DUE TO CHEMOTHERAPY OF BREAST-CANCER - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Journal of clinical oncology, 15(3), 1997, pp. 955-962
Authors:
MEUNIER PJ
CONFAVREUX E
TUPINON I
HARDOUIN C
DELMAS PD
BALENA R
Citation: Pj. Meunier et al., PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS WITH CYCLICAL ETIDRONATETHERAPY (A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY AND 1-YEAR FOLLOW-UP), The Journal of clinical endocrinology and metabolism, 82(9), 1997, pp. 2784-2791
Authors:
MEUNIER PJ
CONFAVREUX E
TUPINON I
HARDOUIN C
DELMAS PD
BALENA R
Citation: Pj. Meunier et al., PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS WITH CYCLICAL ETIDRONATETHERAPY (A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY AND 1-YEAR FOLLOW-UP) (VOL 82, PG 2784, 1997), The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3740-3740
Authors:
HERD RJM
BALENA R
BLAKE GM
RYAN PJ
FOGELMAN I
Citation: Rjm. Herd et al., THE PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY CYCLICAL ETIDRONATE THERAPY - A 2-YEAR, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, The American journal of medicine, 103(2), 1997, pp. 92-99
Citation: P. Masarachia et al., COMPARISON OF THE DISTRIBUTION OF H-3 ALENDRONATE AND H-3 ETIDRONATE IN RAT AND MOUSE BONES, Bone, 19(3), 1996, pp. 281-290
Authors:
HEATH DA
BULLIVANT BG
WEBBER D
PACK S
BALENA R
Citation: Da. Heath et al., EFFECTS OF CYCLICAL ETIDRONATE THERAPY IN THE PREVENTION OF BONE LOSSIN EARLY POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 11, 1996, pp. 644-644
Authors:
BALENA R
MARKATOS A
SEEDOR JG
GENTILE M
STARK C
PETER CP
RODAN GA
Citation: R. Balena et al., LONG-TERM SAFETY OF THE AMINOBISPHOSPHONATE ALENDRONATE IN ADULT DOGS.2. HISTOMORPHOMETRIC ANALYSIS OF THE L5 VERTEBRAE, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 277-283
Citation: M. Gentile et al., INTERLEUKIN-1-BETA GENE DELETION (KNOCKOUT) DOES NOT REDUCE BONE LOSSIN OVARIECTOMIZED MICE, Journal of bone and mineral research, 10, 1995, pp. 242-242
Citation: P. Masarachia et al., COMPARISON OF THE DISTRIBUTION OF H-3 ALENDRONATE AND H-3 ETIDRONATE IN RAT AND MOUSE BONES, Journal of bone and mineral research, 10, 1995, pp. 250-250
Authors:
MEUNIER PJ
CONFAVREUX E
TUPINON I
HARDOUIN C
LOCKWOOD C
BALENA R
DELMAS PD
Citation: Pj. Meunier et al., CYCLICAL ETIDRONATE THERAPY PREVENTS BONE LOSS IN THE EARLY POSTMENOPAUSAL PERIOD, Journal of bone and mineral research, 10, 1995, pp. 357-357
Authors:
ZEGELS B
BALENA R
EASTELL R
RUSSELL RGG
PACK SE
REGINSTER JY
Citation: B. Zegels et al., EFFECT OF RISEDRONATE ON COLLAGEN CROSS-LINKS IN POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 10, 1995, pp. 455-455
Authors:
ROSEN HN
TOLLIN S
BALENA R
MIDDLEBROOKS VL
BEAMER WG
DONOHUE LR
ROSEN C
TURNER A
HOLICK M
GREENSPAN SL
Citation: Hn. Rosen et al., DIFFERENTIATING BETWEEN ORCHIECTOMIZED RATS AND CONTROLS USING MEASUREMENTS OF TRABECULAR BONE-DENSITY - A COMPARISON AMONG DXA, HISTOMORPHOMETRY, AND PERIPHERAL QUANTITATIVE COMPUTERIZED-TOMOGRAPHY, Calcified tissue international, 57(1), 1995, pp. 35-39
Authors:
LAFAGE MH
BALENA R
BATTLE MA
SHEA M
SEEDOR JG
KLEIN H
HAYES WC
RODAN GA
Citation: Mh. Lafage et al., COMPARISON OF ALENDRONATE AND SODIUM-FLUORIDE EFFECTS ON CANCELLOUS AND CORTICAL BONE IN MINIPIGS - A ONE-YEAR STUDY, The Journal of clinical investigation, 95(5), 1995, pp. 2127-2133
Citation: M. Yamamoto et al., ENDOGENOUS CALCITONIN ATTENUATES PARATHYROID HORMONE-INDUCED CANCELLOUS BONE LOSS IN THE RAT, Endocrinology, 136(2), 1995, pp. 788-795
Authors:
POLI V
BALENA R
FATTORI E
MARKATOS A
YAMAMOTO M
TANAKA H
CILIBERTO G
RODAN GA
COSTANTINI F
Citation: V. Poli et al., INTERLEUKIN-6 DEFICIENT MICE ARE PROTECTED FROM BONE LOSS CAUSED BY ESTROGEN DEPLETION, EMBO journal, 13(5), 1994, pp. 1189-1196
Authors:
BALENA R
MARKATOS A
GENTILE M
MASARACHIA P
SEEDOR JG
RODAN GA
YAMAMOTO M
Citation: R. Balena et al., THE AMINOBISPHOSPHONATE ALENDRONATE INHIBITS BONE LOSS INDUCED BY THYROID-HORMONE IN THE RAT COMPARISON BETWEEN EFFECTS ON TIBIAE AND VERTEBRAE, Bone, 14(3), 1993, pp. 499-504
Authors:
LAURITZEN DB
BALENA R
SHEA M
SEEDOR JG
MARKATOS A
LE HM
TOOLAN BC
MYERS ER
RODAN GA
HAYES WC
Citation: Db. Lauritzen et al., EFFECTS OF COMBINED PROSTAGLANDIN AND ALENDRONATE TREATMENT ON THE HISTOMORPHOMETRY AND BIOMECHANICAL PROPERTIES OF BONE IN OVARIECTOMIZED RATS, Journal of bone and mineral research, 8(7), 1993, pp. 871-879
Authors:
YAMAMOTO M
BALENA R
MARKATOS A
GENTILE M
GARSKY VM
RODAN GA
Citation: M. Yamamoto et al., DIRECT DEMONSTRATION OF INHIBITORY EFFECT OF ECHISTATIN ON PTH-INDUCED BONE-RESORPTION IN-VIVO IN MICE, Journal of bone and mineral research, 8, 1993, pp. 190000123-190000123
Authors:
BALENA R
COSTANTINI F
YAMAMOTO M
MARKATOS A
CORTESE R
RODAN GA
POLI V
Citation: R. Balena et al., MICE WITH IL-6 GENE KNOCK-OUT DO NOT LOSE CANCELLOUS BONE AFTER OVARIECTOMY, Journal of bone and mineral research, 8, 1993, pp. 190000130-190000130
Authors:
GUY JA
SHEA M
BALENA R
SEEDOR JG
RODAN G
HAYES WC
Citation: Ja. Guy et al., THE BISPHOSPHONATE ALENDRONATE PRESERVES BOTH THE MECHANICAL-PROPERTIES AND BONE-MINERAL DENSITY IN THE AGING ESTROGEN-DEFICIENT RAT, Journal of bone and mineral research, 8, 1993, pp. 190000134-190000134
Citation: M. Yamamoto et al., ENDOGENOUS CALCITONIN REDUCES PTH-INDUCED BONE-RESORPTION IN RATS, Journal of bone and mineral research, 8, 1993, pp. 190000191-190000191